Table 2

Angiographic Features and Procedural Outcomes Stratified by Gender and Stent Type

SESBMSSES vs. BMS
OutcomeMen (n = 627)Women (n = 247)p ValueMen (n = 621)Women (n = 248)p ValueMen p ValueWomen p Value
Left ventricular ejection fraction (mean ± SD), %56.6 ± 11.157.9 ± 10.60.1256.3 ± 10.859.7 ± 11.10.00010.650.09
Multivessel coronary disease, %41.630.90.00339.736.70.440.480.18
Left anterior descending artery target vessel46.946.00.8245.848.80.450.730.58
Lesion length (mean ± SD), mm13.9 ± 5.613.8 ± 5.90.8313.9 ± 5.813.7 ± 6.20.730.920.95
Baseline RVD (mean ± SD), mm2.71 ± 0.452.72 ± 0.450.932.74 ± 0.492.66 ± 0.450.010.340.13
Baseline MLD (mean ± SD), mm0.93 ± 0.360.97 ± 0.390.190.94 ± 0.370.91 ± 0.350.360.780.09
Baseline percent DS (mean ± SD)65.6 ± 11.664.3 ± 12.80.1865.7 ± 11.665.5 ± 11.40.770.840.30
Final RVD (mean ± SD), mm2.77 ± 0.412.75 ± 0.420.592.79 ± 0.472.69 ± 0.420.0030.350.13
Final MLD (mean ± SD), mm
 In-segment2.27 ± 0.462.29 ± 0.450.622.29 ± 0.472.22 ± 0.450.0560.460.11
 In-stent2.59 ± 0.412.57 ± 0.380.482.59 ± 0.422.52 ± 0.400.020.980.17
Final percent DS (mean ± SD)
 In-segment18.1 ± 10.116.9 ± 9.20.0917.9 ± 9.517.6 ± 9.30.570.810.43
 In-stent6.7 ± 8.67.3 ± 7.60.317.5 ± 8.66.4 ± 8.70.120.980.27
Acute gain (mean ± SD), mm
 In-segment1.34 ± 0.481.32 ± 0.460.591.35 ± 0.491.31 ± 0.440.150.560.73
 In-stent1.66 ± 0.431.60 ± 0.430.081.65 ± 0.441.60 ± 0.400.120.870.92
Final TIMI flow grade 3, %99.199.51.0088.992.70.100.451.00
Stent length (mean ± SD), mm20.9 ± 7.121.0 ± 7.20.8220.2 ± 6.921.4 ± 8.00.040.100.54
Use of GP IIb/IIIa receptor inhibitors, %44.044.60.9342.445.70.400.600.85
Procedure success, %97.698.40.6198.796.80.080.200.25

DS = diameter stenosis; GP = glycoprotein; MLD = minimal lumen diameter; RVD = reference vessel diameter; TIMI = Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.